- In September 2022, the Indian Council of Agricultural Research (ICAR) expressed confidence in commercializing its indigenously developed Lumpi-ProVacInd vaccine for the lumpy skin disease (LSD) virus affecting cattle within the next four to five months. This vaccine has shown promising results and is expected to be commercialized soon, addressing a critical gap in livestock health management.
